Idiopathic Pulmonary Fibrosis Registry for Future Studies

Completed

• Conditions: Lung Disease, Interstitial; Idiopathic Pulmonary Fibrosis

• Registration Number: NCT00815711
• Lead Sponsor: Ohio State University

Brief Summary

To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.

Detailed Description

To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with physiologic measures that follow patients through their course will allow the following proposed studies as well as future investigations to be efficiently carried out.

Study Timeline

• Study Start: 2008-12-01
• Study First Submitted: 2008-12-29
• Study First Submitted QC: 2008-12-29
• Study First Posted: 2008-12-30
• Primary Completion: 2015-06-10
• Study Completion: 2015-06-10
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-01
• Last Update Posted: 2021-11-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

• any patient referred to the Interstitial Lund Disease clinic who is undergoing evaluation and or treatment for a new diagnosis of ILD. This can include patients referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP), sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia, drug-induced, or other idiopathic ILDs.

Exclusion Criteria

• pregnancy
• inability to follow study requirements

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Framework	7 + years	To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated

Trial Locations

Locations (1)

The Ohio State University; 🇺🇸 Columbus, Ohio, United States